NCT01699113View on ClinicalTrials.gov

Effects of YF476 and Rabeprazole on Gastric Function

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Hypergastrinaemia
Interventions
DRUG

YF476

"Subjects will be randomised to once daily treatment by mouth for 6 weeks with:~* YF476 100 mg; or~* rabeprazole 20 mg; or~* a combination of YF476 100 mg and rabeprazole 20 mg."

DRUG

Rabeprazole

"Subjects will be randomised to once daily treatment by mouth for 6 weeks with:~* YF476 100 mg; or~* rabeprazole 20 mg; or~* a combination of YF476 100 mg and rabeprazole 20 mg."

Trial Locations (1)

Unknown

Hammersmith Medicines Research, London

All Listed Sponsors
lead

Trio Medicines Ltd.

INDUSTRY

NCT01699113 - Effects of YF476 and Rabeprazole on Gastric Function | Biotech Hunter | Biotech Hunter